Invest in Legend Biotech Corp. Sponsored ADR on Stash
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications.
Ticker: LEGN
Legend Biotech Corp. Sponsored ADR
$27.38
-6.84%
$
LEGN Performance Breakdown
Share Price
$27.38
Today's change
-1.76%
Year to date change (YTD)
27.29%
Dividend yield
0.0
Last dividend paid
N/A
Last dividend pay date
N/A
About LEGN
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Legend Biotech Corp. Sponsored ADR Stock Ticker
LEGN
For more information
Invest in Legend Biotech Corp. Sponsored ADR on Stash
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications.
Certain companies are volatile
Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.
Legend Biotech Corp. Sponsored ADR stock news
Why invest with Stash?
Fractional shares
Thousands of stocks and ETFs. No investing minimums.
Unlimited trades
Plus no add-on trading commission fees.†
Diversification analysis
Custom investment recommendations can help you diversify.
Automatic investing
Dividend reinvestment,8 recurring investments, and more.
The Stock-Back® Card
We’ll give you matching stock in companies you shop at.1
Learn how to invest
Get professional advice and education at every step.
How to buy Legend Biotech Corp. Sponsored ADR stock on Stash
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Stash offers one subscription plan: The Stash Plan.
Once your market order of Legend Biotech Corp. Sponsored ADR stock is complete, you'll officially be a shareholder of Legend Biotech Corp. Sponsored ADR!
Invest in Legend Biotech Corp. Sponsored ADR on Stash
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications.
More Health Care stocks
First Tracks Biotherapeutics, Inc.
53.01%
Semnur Pharmaceuticals, Inc.
18.46%
10x Genomics Inc Class A
12.86%
CONMED Corp
12.03%
Neurogene, Inc.
11.96%
Hemab Therapeutics Holdings, Inc.
9.81%
Damora Therapeutics, Inc.
9.66%
Qiagen NV
9.53%
Butterfly Network Inc.
8.79%
Treace Medical Concepts Inc
8.64%
Tempus AI, Inc. Class A
7.39%



